We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

March 20, 2017

Sanofi-Aventis U.S., LLC et al v. Amgen Inc. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. March 21, 2017

    Sanofi Sues Amgen To Protect Eczema Drug From IP Claims

    Sanofi SA and partner Regeneron Pharmaceuticals sued Amgen Inc. in Massachusetts federal court, seeking a court order declaring that its eczema drug Dupixent doesn’t infringe an Amgen Inc. patent for a failed asthma treatment and to thwart anticipated litigation against it.


Parties

To view the parties, register now.